Omega Therapeutics Inc. announced the appointment of Luke Beshar to its Board of Directors. Mr. Beshar is a corporate finance veteran and most recently served as Executive Vice President and Chief Financial Officer at NPS Pharmaceuticals Inc., through its acquisition by Shire PLC. During his tenure at NPS Pharmaceuticals, Mr. Beshar oversaw financial management, investor relations, technical operations, information technology, quality assurance, project management, contracts & outsourcing, and facilities. Prior to this role, he served as Executive Vice President, Strategy and Corporate Development and Chief Financial Officer of Cambrex Corporation and as Chief Financial Officer of Dendrite International. Earlier in his career, Mr. Beshar held various general and financial management positions of increasing responsibility.